These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9478949

  • 1. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.
    Moir RD, Lynch T, Bush AI, Whyte S, Henry A, Portbury S, Multhaup G, Small DH, Tanzi RE, Beyreuther K, Masters CL.
    J Biol Chem; 1998 Feb 27; 273(9):5013-9. PubMed ID: 9478949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT.
    Brain Res; 2007 Aug 03; 1161():116-23. PubMed ID: 17586478
    [Abstract] [Full Text] [Related]

  • 4. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP, Lopez-Font I, Cuchillo-Ibañez I, Sáez-Valero J.
    Alzheimers Res Ther; 2020 Aug 12; 12(1):96. PubMed ID: 32787955
    [Abstract] [Full Text] [Related]

  • 5. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
    Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, Mudge AW, Jazin E, Cairns NJ.
    Brain Res Mol Brain Res; 2004 Mar 17; 122(1):1-9. PubMed ID: 14992810
    [Abstract] [Full Text] [Related]

  • 6. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
    Palmert MR, Podlisny MB, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Whitehouse PJ, Witker DS, Oltersdorf T.
    Prog Clin Biol Res; 1989 Mar 17; 317():971-84. PubMed ID: 2513588
    [Abstract] [Full Text] [Related]

  • 7. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.
    Ho L, Fukuchi Ki, Younkin SG.
    J Biol Chem; 1996 Nov 29; 271(48):30929-34. PubMed ID: 8940079
    [Abstract] [Full Text] [Related]

  • 8. The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons.
    Caswell MD, Mok SS, Henry A, Cappai R, Klug G, Beyreuther K, Masters CL, Small DH.
    Eur J Biochem; 1999 Dec 29; 266(2):509-16. PubMed ID: 10561592
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and characterization of the Kunitz protease-inhibitor domain of the beta-amyloid precursor protein.
    Schilling J, Wang Y, Lau K, Smith L, Cordell B.
    Gene; 1991 Feb 15; 98(2):225-30. PubMed ID: 1707846
    [Abstract] [Full Text] [Related]

  • 10. LRP-mediated clearance of Abeta is inhibited by KPI-containing isoforms of APP.
    Moir RD, Tanzi RE.
    Curr Alzheimer Res; 2005 Apr 15; 2(2):269-73. PubMed ID: 15974929
    [Abstract] [Full Text] [Related]

  • 11. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT, Tanzi RE, Marzloff K, Barbour R, Schenk D.
    J Neuropathol Exp Neurol; 1992 Jan 15; 51(1):76-83. PubMed ID: 1740675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
    Zhan SS, Sandbrink R, Beyreuther K, Schmitt HP.
    Clin Neuropathol; 1995 Jan 15; 14(3):142-9. PubMed ID: 7671455
    [Abstract] [Full Text] [Related]

  • 14. Expression, purification and characterization of a Kunitz-type protease inhibitor domain from human amyloid precursor protein homolog.
    Petersen LC, Bjørn SE, Norris F, Norris K, Sprecher C, Foster DC.
    FEBS Lett; 1994 Jan 24; 338(1):53-7. PubMed ID: 8307156
    [Abstract] [Full Text] [Related]

  • 15. Improved method for expression of Kunitz-type serine proteinase inhibitor domain of beta-amyloid protein precursor in Escherichia coli and characterization of disulfide bonds of the product.
    Oyama F, Hashino K, Oyama R, Kato I, Titani K.
    J Biochem; 1993 Dec 24; 114(6):813-9. PubMed ID: 8138537
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain.
    Willoughby DA, Rozovsky I, Lo AC, Finch CE.
    J Mol Neurosci; 1995 Dec 24; 6(4):257-76. PubMed ID: 8860237
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders.
    Tanaka S, Liu L, Kimura J, Shiojiri S, Takahashi Y, Kitaguchi N, Nakamura S, Ueda K.
    Brain Res Mol Brain Res; 1992 Oct 24; 15(3-4):303-10. PubMed ID: 1331685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.